ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 191 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2018. The put-call ratio across all filers is 1.26 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $98 | -100.0% | 100 | -98.7% | 0.00% | -100.0% |
| Q4 2019 | $470,000 | +62.6% | 7,876 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $289,000 | -23.3% | 7,876 | -2.9% | 0.00% | 0.0% |
| Q2 2019 | $377,000 | -66.0% | 8,111 | -70.6% | 0.00% | -75.0% |
| Q1 2019 | $1,108,000 | +206.9% | 27,604 | +251.7% | 0.00% | +300.0% |
| Q4 2018 | $361,000 | +7.4% | 7,849 | +3.8% | 0.00% | 0.0% |
| Q3 2018 | $336,000 | +60.8% | 7,562 | +42.0% | 0.00% | 0.0% |
| Q2 2018 | $209,000 | -81.3% | 5,326 | -65.5% | 0.00% | -80.0% |
| Q1 2018 | $1,116,000 | +255.4% | 15,436 | +223.2% | 0.01% | +400.0% |
| Q4 2017 | $314,000 | +119.6% | 4,776 | +54.1% | 0.00% | 0.0% |
| Q2 2017 | $143,000 | +31.2% | 3,100 | -6.1% | 0.00% | 0.0% |
| Q1 2017 | $109,000 | – | 3,301 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 3,791,300 | $3,715,474 | 4.82% |
| Two Seas Capital LP | 7,672,170 | $7,518,727 | 1.51% |
| Parkman Healthcare Partners LLC | 1,997,071 | $1,957,130 | 0.36% |
| Monaco Asset Management SAM | 1,171,779 | $1,148,343 | 0.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,850,000 | $1,813,000 | 0.26% |
| Ikarian Capital, LLC | 1,737,636 | $1,702,883 | 0.20% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 3,189,517 | $3,125,727 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 1,116,655 | $1,094 | 0.09% |
| XTX Topco Ltd | 519,129 | $508,746 | 0.09% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 60,000 | $58,800 | 0.08% |